Adverse events of injected CGRP inhibitors

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1913卷 / 1期
关键词：
D O I：
10.1007/s40278-022-18151-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [21] Immune checkpoint inhibitors and neuromuscular adverse events
    Suzuki, Shigeaki
    ANNALS OF ONCOLOGY, 2018, 29 : 35 - 35
  • [22] The pathology of adverse events with immune checkpoint inhibitors
    Koelzer, V. H.
    Glatz, K.
    Bubendorf, L.
    Weber, A.
    Gaspert, A.
    Cathomas, G.
    Lugli, A.
    Zippelius, A.
    Kempf, W.
    Mertz, K. D.
    PATHOLOGE, 2017, 38 (03): : 197 - 207
  • [23] CGRP INHIBITORS
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 3 - 4
  • [24] NOVEL ADVERSE EVENTS OF CGRP RECEPTOR ANTAGONISTS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Sangnure, A.
    Das, A.
    Sajjan, S.
    Ac, R.
    VALUE IN HEALTH, 2023, 26 (06) : S372 - S373
  • [25] Rheumatological adverse events secondary to immune checkpoint inhibitors
    Garbarino, Maria Cecilia
    Manzano, Natalia
    Messina, Osvaldo
    Zylberman, Marcelo
    REUMATOLOGIA CLINICA, 2023, 19 (04): : 215 - 222
  • [26] Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors
    Khan, Qamar J.
    O'Dea, Anne P.
    Sharma, Priyanka
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [27] Adverse Events of Proton Pump Inhibitors: Potential Mechanisms
    Corsonello, Andrea
    Lattanzio, Fabrizia
    Bustacchini, Silvia
    Garasto, Sabrina
    Cozza, Annalisa
    Schepisi, Roberto
    Lenci, Federica
    Luciani, Filippo
    Maggio, Marcello Giuseppe
    Ticinesi, Andrea
    Butto, Valeria
    Tagliaferri, Sara
    Corica, Francesco
    CURRENT DRUG METABOLISM, 2018, 19 (02) : 142 - 154
  • [28] Exploring and comparing adverse events between PARP inhibitors
    LaFargue, Christopher J.
    Dal Molin, Graziela Z.
    Sood, Anil K.
    Coleman, Robert L.
    LANCET ONCOLOGY, 2019, 20 (01): : E15 - E28
  • [29] JAK inhibitors: risk of major adverse cardiovascular events
    Reactions Weekly, 2025, 2052 (1) : 8 - 8
  • [30] JAK-Inhibitors - A Story of Success and Adverse Events
    Wlassits, Rebekka
    Mueller, Mathias
    Fenzl, Karl H.
    Lamprecht, Thomas
    Erlacher, Ludwig
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2024, 16 : 43 - 53
12345